tiprankstipranks
Transgene SA (GB:0OCQ)
LSE:0OCQ

Transgene (0OCQ) Financial Statements

2 Followers

Transgene Financial Overview

Transgene's market cap is currently ―. The company's EPS TTM is €-0.223; its P/E ratio is -5.91; Transgene is scheduled to report earnings on September 24, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 26.83M€ 42.84M€ 49.57M€ 48.08M€ 26.35M
Total Assets€ 66.44M€ 85.72M€ 101.84M€ 106.92M€ 85.45M
Total Debt€ 2.45M€ 3.20M€ 3.84M€ 4.53M€ 5.12M
Net Debt€ -24.38M€ -39.64M€ -45.73M€ -43.55M€ -21.23M
Total Liabilities€ 28.59M€ 31.32M€ 34.63M€ 34.28M€ 34.74M
Stockholders Equity€ 37.84M€ 54.40M€ 67.21M€ 72.64M€ 50.72M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

Transgene Earnings and Revenue History

Transgene Debt to Assets

Transgene Cash Flow

Transgene Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis